MBX Biosciences Submits IND for Once-Monthly Obesity Drug
MBX Biosciences Inc. (NASDAQ:MBX) is one of the best IPO stocks to buy according to Wall Street analysts.
Mbx Biosciences Inc. (MBX)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 666,666 | $11,999,988.00 | 5,219,440 | 2025-09-26 | Filing | |
| $5.89 | 7,693 | $45,311.77 | 24,329 | 2025-04-08 | Filing | |
| $10.84 | 94,100 | $1,020,044.00 | 747,887 | 2025-02-18 | Filing | |
| $10.84 | 49,070 | $531,918.80 | 3,255,000 | 2025-02-18 | Filing | |
| $9.85 | 29,540 | $290,969.00 | 3,205,930 | 2025-02-14 | Filing |
News See All
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
Hedge Fund Resource Center Billionaire Hedge Funds
